ENTPD1 and liver cancer: Further experimentation suggests the development of autochthonous liver cancer in Entpd1/Cd39−/− mice (97), resulting from comparable eATP-P2 receptor-mediated changes: inclusive of suppression of liver cell autophagy, altered metabolism, and boosting of proliferation.